Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen.

Hyun Seok Lee Seong Woo JeonSachiyo NomuraYasuyuki SetoYong Hwan KwonSu Youn NamYuko IshibashiHiroshi OhtsuYasukazu OhmotoHae Min Yang

Published in: Gastroenterology research and practice (2018)

The combination of serum TFF3 and pepsinogen is a more effective noninvasive biomarker for gastric cancer detection compared with pepsinogen or TFF3 alone, even in EGC. This trial is registered with NCT03046745.

Keyphrases

loop mediated isothermal amplification
real time pcr
label free
study protocol
clinical trial
randomized controlled trial
small bowel
sensitive detection
open label